Recent Finacing
Recent Raise
Neuraltus Pharmaceuticals develops therapeutics for degenerative neurological diseases, advancing ALS and Parkinson's drug candidates through early-stage clinical development.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors